Related Experiment Video
Updated: May 20, 2026
09:02
Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
Published on: September 27, 2024
Nanotechnology applications for glioblastoma
Edjah K Nduom1, Alexandros Bouras, Milota Kaluzova
1Department of Neurosurgery, Emory University School of Medicine, Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA.
Neurosurgery Clinics of North America
|July 4, 2012
Summary
Glioblastoma, a challenging brain cancer, often recurs due to infiltrating cells. Cancer nanotechnology offers new hope for targeted therapies and imaging to combat these persistent cancer cells.
Area of Science:
- Oncology
- Biomedical Engineering
- Nanotechnology
Background:
- Glioblastoma is the most common and difficult-to-treat primary brain malignancy.
- Conventional treatments show limited success against infiltrating cancer cells, leading to recurrence and mortality.
- Targeting residual disease is crucial for improving glioblastoma patient outcomes.
Purpose of the Study:
- To review the current applications of nanotechnology in glioblastoma treatment.
- To explore the potential of multifunctional nanoparticles for glioblastoma therapy and imaging.
- To identify future research directions in nanomedicine for glioblastoma.
Main Methods:
- Review of current literature on nanotechnology in glioblastoma research.
- Analysis of nanoparticle-based strategies for glioblastoma imaging and targeted therapy.
- Discussion of challenges and future prospects in the field.
Main Results:
- Nanoparticles show promise for enhanced glioblastoma imaging.
- Targeted drug delivery systems using nanoparticles can improve therapeutic efficacy.
- Multifunctional nanoparticles offer combined diagnostic and therapeutic capabilities.
Conclusions:
- Nanotechnology presents a promising avenue for overcoming glioblastoma treatment challenges.
- Further research is needed to translate nanotechnological advancements into clinical practice.
- Targeted nanoparticle-based therapies hold potential for improved glioblastoma management.
